| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |